Abstract
Obesity has increasingly been recognized as an epidemic in the United States. The incidence of obesity has risen such that the most recent National Health and Nutrition Examination Survey (NHANES 1999–2000) demonstrates that two-thirds of Americans are classified as overweight or obese (1). A person’s adiposity is typically described in terms of body mass index (BMI), defined as a person’s weight (kg) divided by body surface area (m2), at which obesity starts at a BMI of 30 kg/m2. This rise in obesity is closely associated with increases in numerous related diseases such as type 2 diabetes mellitus, coronary artery disease, hypertension, dyslipidemia, asthma, obstructive sleep apnea, gastroesophageal reflux, stroke, certain types of cancer, degenerative joint disease, and depression (2,3). Obese individuals may suffer from diminished life expectancy, depending on the age of onset of obesity (2–5 yr for those who are moderately obese and 5–20 yr for those with severe obesity) (4). This increased mortality contributes to approx 280,000 deaths annually in the United States alone (5). The economic cost of combating obesity and associated comorbidities is estimated to exceed $100 billion annually in the United States (6).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Flegal KM, Ogden CM, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;14:1723–1727.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523–1529.
Consensus Development Conference Panel. NIH conference: gastrointestinal surgery for severe obesity Ann Intern Med 1991;115:956–961.
Fontaine KR, et al. Years of life lost due to obesity. JAMA 2003;289:187–193.
Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530–1538.
Wolf A, Colditz G. Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6:97–106.
National Heart, Lung, and Blood Institute, Public Health Service, U.S. Department of Health and Human Services, eds. Expert Panel: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. National Institutes of Health, Bethesda, MD:1998.
Steinbrook R. Surgery for severe obesity. N Engl J Med 2004;350:1075–1079.
Payne JH, DeWind LT. Surgical treatment of obesity. Am J Surg 1969;118:141–147.
Deitel M, Shahi B, Anand PK, Deitel FH, Cardinell DL. Long-term outcome in a series of jejunoileal bypass patients. Obes Surg 1993;3:247–252.
Requarth JA, Burchard KW, Colacchio TA, et al. Long-term morbidity following jejunoileal bypass: the continuing potential need for surgical reversal. Arch Surg 1995;130:318–325.
Kroyer JM, Talbert WM Jr. Morphologic liver changes in intestinal bypass patients. Am J Surg 1986;139:855–859.
Halverson JD, Wise L, Wazna MF, Ballinger WF. Jejunoileal bypass for morbid obesity: a critical appraisal. Am J Med 1978;64:461–475.
Greenway SE, G.F. Root surface caries: a complication of jejunoileal bypass. Obes Surg 2000;10:33–36.
Griffen WO Jr, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg 1977;186:500–509.
Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg 1998;22:936–946.
Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001;120:669–681.
Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996;119:261–268.
Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998;8:267–282.
Murr MM, Balsiger BM, Kennedy FP, Mai JL, Sarr MG. Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass. J Gastrointest Surg 1999;3:607–612.
Jones D, Provost D, De Maria EJ, Smith CD, Morgenstern L, Schirmer B. Optimal management of the morbidly obese patient SAGES appropirateness conference statement. Surg Endosc 2004;18:1029–1037.
Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982;117:701–706.
Pace WG, Martin EW Jr, Tetirick T, Fabri PJ, Carey LC. Gastric partitioning for morbid obesity. Ann Surg 1979;190:392–400.
MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg 1993;165:155–160; discussion 160–152.
Nightengale ML, Sarr MG, Kelly KA, Jensen MD, Zinsmeister AR, Palumbo PJ. Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity [see comments]. Mayo Clin Proc 1991;66:773–782.
Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000;4:598–605.
Balsiger BM, Murr MM, Mai J, Sarr MG. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. J Gastrointest Surg 2000;4:276–281.
Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987;205:613–624.
Sugerman HJ, Londrey GL, Kellum JM, et al. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 1989;157:93–102.
O’Brien PE, Dixon JB. Weight loss and early and late complications—the international experience. Am J Surg 2002;184:42S–45S.
Angrisani L, Furbetta F, Doldi B, et al. Lap-Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years. Surg Endosc 2003;17:409–412.
Schneider B, Sanchez V, Jones D. How to implant the laparoscopic adjustable gastric band for morbid obesity. Contemp Surg 2004;60:248–264.
FDA Trial Summary of Safety and Effectiveness Data: The Lap-Band Adjustable Gastric Banding System (P000008). http://www.fda.gov/cdrh/pdf/p000008.htm.
Ren CJ, Horgan S, Ponce J. US experience with the LAP-BAND System. Am J Surg 2002;184:46S–50S.
Rubenstein R. Laparoscopic adjustable gastric banding at a US center with up to 3-year follow-up. Obes Surg 2002;12:380–384.
Fielding GA, Rhodes M, Nathanson LK. Laparoscopic gastric banding for morbid obesity: surgical outcome in 335 cases. Surg Endosc 1999;13:550–554.
DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg 2002;235:640–645; discussion 645–647.
Angrisani L, Furbetta F, Doldi B, et al. Lap-Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years. Surg Endosc 2003;17:409–412.
DeMaria EJ. Laparoscopic adjustable silicone gastric banding. Surg Clin North Am 2001;81:1129–1144, vii.
Weiner R, Wagner D, Bockhorn H. Laparoscopic gastric banding for morbid obesity. J Laparoendosc Adv Surg Tech A 1999;9:23–30.
Weiner R, Blanco-Engert R, Weiner S, et al. Outcome after laparoscopic adjustable gastric banding-8 years experience. Obes Surg 2003;13:427–434.
Dargent J. Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution. Obes Surg 1999;9:446–452.
O’Brien PE, Dixon JB. The extent of the problem of obesity. Am J Surg 2002;184:4S–8S.
Favretti F, Cadiere GB, Segato G, et al. Laparoscopic banding: selection and technique in 830 patients. Obes Surg 2002;12:385–390.
Mason EE, Ito C. Gastric bypass. Ann Surg 1969;170:329–339.
Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg 1994;4:353–357.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623–1630.
Schneider BE, Villegas L, Blackburn GL, Mun EC, Critchlow JF, Jones DB. Laparoscopic gastric bypass surgery: outcomes. J Laparoendosc Adv Surg Tech A 2003;13:247–255.
Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 2004;199:543–551.
Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients—what have we learned? Obes Surg 2000;10:509–513.
Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515–529.
Schauer P, Ikramuddin S., Hamad G, Gourash W. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc. 2003;17:212–215.
Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3–60 month follow-up. Obes Surg 2000;10:233–239.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339–350; discussion 350–352.
Matthews BD, Sing RF, DeLegge MH, Ponsky JL, Henniford BT. Initial results with a stapled gastrojejunostomy for the laparoscopic isolated Roux-en-Y gastric bypass. Am J Surg 2000;179:476–480.
Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234:279–289; discussion 289–291.
Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg 2000;135:1029–1033; discussion 1033–1034.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–1737.
Dixon JB, Dixon AF, O’Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese: homeostatic model assessment. Diabet Med 2003;20:127–134.
Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358–363.
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467–484.
Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477–484.
Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237:751–756; discussion 757, 758.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Schneider, B.E., Mun, E.C. (2006). Surgical Treatment of Obesity and Diabetes. In: Mantzoros, C.S. (eds) Obesity and Diabetes. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-59259-985-1_28
Download citation
DOI: https://doi.org/10.1007/978-1-59259-985-1_28
Publisher Name: Humana Press
Print ISBN: 978-1-58829-538-5
Online ISBN: 978-1-59259-985-1
eBook Packages: MedicineMedicine (R0)